| Next 10 |
Ad
DMPI News and Press DelMar Pharmaceuticals
News | DelMar Pharmaceuticals (NASDAQ:DMPI)
-
DelMar Pharmaceuticals ( DMPI +6.9% ) announces direct offering of 19,587 convertible preferred shares for the gross proceeds of ~$19.6M. That makes the offering priced at-the-market on $1,000 per share. More news on: DelMar Pharmaceuticals, Inc., , Stocks on the move, Healthcar...
-
SAN DIEGO , Aug. 18, 2020 /PRNewswire/ -- DelMar Pharmaceuticals, Inc. (Nasdaq: DMPI) ("DelMar" or the "Company") announced today that it has entered into definitive agreements with investors providing for the sale and issuance of up to 19,587 shares of its Series C Convert...
-
DelMar Pharmaceuticals (NASDAQ: DMPI ) announces that all proposals related to the merger between DelMar and Adgero were approved by the stockholders at a special meeting held on August 14, 2020. More news on: DelMar Pharmaceuticals, Inc., Healthcare stocks news, Read more ...
-
SAN DIEGO , Aug. 17, 2020 /PRNewswire/ -- DelMar Pharmaceuticals, Inc. (Nasdaq: DMPI) ("DelMar" or the "Company") announced today that all proposals related to the proposed merger between DelMar and Adgero were approved by DelMar's stockholders at a special meeting held on August 14...
-
Unity Biotechnology (NASDAQ: UBX ) -51% on stumble with lead drug . More news on: Unity Biotechnology, Inc., Interpace Biosciences, Inc., Taiwan Liposome Company, Ltd., Stocks on the move, , Read more ...
-
Spectrum Pharmaceuticals (NASDAQ: SPPI ) -18% after pricing equity offering. More news on: Spectrum Pharmaceuticals, Inc., Global Eagle Entertainment Inc., JAKKS Pacific, Inc., Stocks on the move, , Read more ...
-
Gainers: Milestone Pharmaceuticals (NASDAQ: MIST ) +105% . More news on: Milestone Pharmaceuticals Inc., RigNet, Inc., Brightcove Inc., Stocks on the move, , Read more ...
-
Verb Technology Company (NASDAQ: VERB ) -25% after pricing equity offering. More news on: Verb Technology Company, Inc., Tonix Pharmaceuticals Holding Corp., Novan, Inc., Stocks on the move, , Read more ...
-
The FDA designates privately held Denovo Biopharma 's lead candidate DB102 (enzastaurin) for Fast Track review for the treatment of newly diagnosed glioblastoma , an aggressive cancer of the brain or spinal cord. More news on: Eli Lilly and Company, MediciNova, Inc., ZIOPHARM Oncology,...
-
SAN DIEGO , July 17, 2020 /PRNewswire/ -- DelMar Pharmaceuticals, Inc. (Nasdaq: DMPI) ("DelMar" or the "Company"), a biopharmaceutical company focused on the development of new solid tumor cancer therapies announced today that it will be conducting a conference call to discuss...
Stock Information
Get DMPI Alerts
News, Short Squeeze, Breakout and More Instantly...
DelMar Pharmaceuticals Company Name:
DMPI Stock Symbol:
NASDAQ Market:
DelMar Pharmaceuticals Website:
Ad
-
SAN DIEGO , Aug. 18, 2020 /PRNewswire/ -- DelMar Pharmaceuticals, Inc. (Nasdaq: DMPI) ("DelMar" or the "Company") announced today that it has entered into definitive agreements with investors providing for the sale and issuance of up to 19,587 shares of its Series C Convert...
-
SAN DIEGO , Aug. 17, 2020 /PRNewswire/ -- DelMar Pharmaceuticals, Inc. (Nasdaq: DMPI) ("DelMar" or the "Company") announced today that all proposals related to the proposed merger between DelMar and Adgero were approved by DelMar's stockholders at a special meeting held on August 14...
-
SAN DIEGO , July 17, 2020 /PRNewswire/ -- DelMar Pharmaceuticals, Inc. (Nasdaq: DMPI) ("DelMar" or the "Company"), a biopharmaceutical company focused on the development of new solid tumor cancer therapies announced today that it will be conducting a conference call to discuss...
Important Investor News Alert (OTC: AABB)
-
LAS VEGAS, Sept. 11, 2024 (GLOBE NEWSWIRE) -- Asia Broadband Inc. (OTC: AABB) (“AABB” or the “Company”) is pleased to announce that the Company is expecting the completion of a resource technical report in the fourth quarter for the Tequila Gold Mine Project locate...